Sodium butyrate increases the effect of the photodynamic therapy: A mechanism that involves modulation of gene expression and differentiation in astrocytoma cells

Child's Nervous System

Volumn 28, Issue 10, 2012, Pages 1723-1730

  Bueno Carrazco, José ^a   Castro Leyva, Violeta ^a   García Gomez, Fanny ^a   Solís Paredes, Mario ^a   Ramon Gallegos, Eva ^a   Cruz Orea, Alfredo ^b   Eguía Aguilar, Pilar ^c   Arenas Huertero, Francisco ^a,c,d  

^a INSTITUTO TECNOLÓGICO DE SONORA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

^d HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

Author keywords

Acetylation; Gliomas .Deathcell .Cellculture .RNA HDAC; Laser

Indexed keywords

AMINOLEVULINIC ACID; BAK 1 PROTEIN; BUTYRIC ACID; CASPASE 3; CASPASE 9; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTOPORPHYRIN; UNCLASSIFIED DRUG; UROPORPHYRINOGEN; UROPORPHYRINOGEN SYNTHASE;

ARTICLE; ASTROCYTOMA CELL; CANCER INHIBITION; CELL DEATH; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; DNA SYNTHESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ASTROCYTOMA; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BUTYRATES; CASPASES; CELL DEATH; CELL DIFFERENTIATION; CELL LINE, TUMOR; DENSITOMETRY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; PHOTOSENSITIZING AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTOPORPHYRINS;

EID: 84867582398     PISSN: 02567040     EISSN: 14330350     Source Type: Journal    
DOI: 10.1007/s00381-012-1828-3     Document Type: Article

References (28)

1. Chico-Ponce de León F, Castro-Sierra E, Pérezpeña- Diazconti M, Gordillo-Domínguez LF, Santana-Montero BL, Rocha-Rivero LE, Vaca-Ruíz MA, Ríos-Alanís M, Sánchez-Herrera F, Valdéz- Orduño R (2006) Tumores intracraneanos del niño. Bol Med Hosp Infant Mex 63:367-381
2. Kleihues P, Ohgaki H (1999) Primary and secondary glioblastomas: from concept to clinical diagnosis. Neurooncology 1:44-51
3. Schmidt-Erfurth U, Diddens H, Birngruber R, Hasan T (1997) Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates. Br J Cancer 75:54-61
4. Kessel D, Woodburn K (1993) Biodistribution of photosensitizing agents. Int J Biochem 25:1377-1383
5. Oleinick NL, Morris RL, Belichenko I (2002) The role of apoptosis in response to photodynamic therapy: what, where, why and how. Photochem Photobiol Sci 1:1-21
6. Wu SM, Ren QG, Zhou MO, Peng Q, Chen JY (2003) Protopporphyrin IX production and its photodynamic effects on glioma cells, neuroblastoma cells and normal cerebellar granule cells in vitro with 5-aminolevulinic acid and its hexylester. Cancer Let 200:123-131
7. Ruiz-Galindo E, Arenas-Huertero F, Ramón-Gallegos E (2007) Expression of genes involved in heme biosynthesis in the human retinoblastoma cell lines WERI-Rb-1 and Y79: implications for photodynamic therapy. J Exp Clin Cancer Res 26:195-200
8. Olivo M, Wilson BC (2004) Mapping ALA-induced PPIX fluorescence in normal brain and brain tumour using confocal fluorescence microscopy. Int J Oncol 25:37-45
9. Dailey HA, Smith A (1984) Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase. Biochem J 223:441-445
10. Wild PJ, Krieg RC, Seidl J et al (2005) RNA expression profiling of normal and tumor cells following photodynamic therapy with 5- aminolevulinic acid-induced protoporphyrin IX in vitro. Mol Cancer Ther 4:516-528
11. Urnov FD (2003) Chromatin remodeling as a guide to transcriptional regulatory networks in mammals. J Cell Biochem 88:684-694
12. Gore SD, Carducci MA (2000) Modifying histones to care cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors. Expert Opin Invest Drugs 9:2923-2934
13. Marks PA, Richon VM, Rifkind RA (2000) Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 92:1210-1216
14. Widmer J, Fassihi KS, Schlichter SC, Wheeler KS, Crute BE, King N, Nutile-McMenemyN, NollWW, Daniel S,Ha J, KimKH,Witters LA (1996) Identification of a second human acetyl-CoA carboxylase gene. Biochem J 316:915-922
15. Wang J, Saunthararajah Y, Redner RL, Liu JM (1999) Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells. Cancer Res 59:2766-2769
16. Butler LM, Agus DB, Scher HI, Higgins B, Rose A, Cordon-Cardo C, Thaler HT, Rifkind RA, Marks PA, Richon VM (2000) Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res 60:5165-5170
17. Piomelli SA (1973) Micromethod for free erythrocyte porphyrins: the FEP test. J Lab Clin Med 81:932-940
18. Ramón-Gallegos E, DeLeón-Rodríguez I, Martínez-Guzmán LA, Pérez-Zapata AJ (1999) In vitro study of biosíntesis of protoporphyrin IX induced by δ-aminolevulinic acid in normal and cancerous cells of the human cervix. Arch Med Res 30:163-170
19. Kennedy JC, Pottier RH, Pross DC (1990) Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol 6:143-148
20. Kemmner W, Wan K, Rüttinger S et al (2008) Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer. FASEB J 22:500-509
21. Uzdensky A, Juzeniene A, Ma LW, Moan J (2004) Photodynamic inhibition of enzymatic detachment of human cancer cells from a substratum. Biochem Biophys Res Commun 322:452-457
22. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619
23. Neise D, Graupner V, Gillissen BF, Daniel PT, Schulze-Osthoff K, Janicke RU, Essmann F (2008) Activation of the mitochondrial death pathway is commonly mediated by a preferential engagement of Bak. Oncogene 27:1387-1396
24. Karmakar S, Banik NL, Patel SJ, Ray SK (2007) 5-Aminolevulinic acid-based photodynamic therapy suppressed survival factors and activated proteases for apoptosis in human glioblastoma U87MG cells. Neurosci Lett 415:242-247
25. Ortel B, Chen N, Brissette J, Dotto GP, Maytin E, Hasan T (1998) Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes. Br J Cancer 77:1744-1751
26. Appelskog IB, Ammerpohl O, Svechnikova IG, Lui WO, Almqvist PM, Ekström TJ (2004) Histone deacetylase inhibitor 4- phenylbutyrate suppresses GAPDH mRNA expression in glioma cells. Int J Oncol 24:1419-1425
27. Flores-Ancona RM, Garcia-Gomez FY, Jimenez-Betanzos AM, Solis-Paredes M, Castro-Leyva V, Cruz-Orea A, Arenas-Huertero F, Ramon-Gallegos E (2009) Effects of sodium butyrate on cell death induced by photodynamic therapy in U373-MG and D54- MG astrocytoma cell lines. Photochem Photobiol 85:1182-1188
28. Li X-N, Shu Q, Su JM-F, Perlaky L, Blaney SM, Lau Ch C (2005) Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC. Mol Cancer Ther 4:1921-1922